Infant Bacterial Therapeutics ABIBT.B 
$3.38-1.71%24h
-1.71%24h
Global rank25921
Market cap$44.00M
Change 7d-13.53%
YTD Performance-61.67%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Category
Market capitalization of Infant Bacterial Therapeutics AB (IBT.B)
As of November 2024, Infant Bacterial Therapeutics AB has a market cap of $44.00M. This makes Infant Bacterial Therapeutics AB the world's 25921th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Infant Bacterial Therapeutics AB from 2016 to 2024
-
Value:-
Market cap history of Infant Bacterial Therapeutics AB from 2016 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $120.89M | 5.33% |
| 2023 | $114.77M | 80.00% |
| 2022 | $63.76M | -25.15% |
| 2021 | $85.18M | -40.36% |
| 2020 | $142.82M | -21.68% |
| 2019 | $182.36M | 1.06% |
| 2018 | $180.44M | 37.47% |
| 2017 | $131.26M | 161.36% |
| 2016 | $50.22M | - |
IBT.B Market Cap Today is $44.00M -1.71% - 12 Nov 2024
View largest stocks by market cap 
